The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A long noncoding RNA connects c-Myc to tumor metabolism
Open accessAbstract
Significance: Long noncoding RNA (lncRNA) has been implicated in carcinogenesis and regarded as an emerging alternative target for cancer therapy. This study provides, to our knowledge, the first case of lncRNA that serves as a coactivator of c-Myc and a master regulator of tumor metabolism. This lncRNA, prostate cancer gene expression marker 1 ( PCGEM1 ), is overexpressed in prostate cancer and implicated in castration resistance. It also forms an independent complex with androgen receptor (AR). Being a dual coactivator for AR and c-Myc, PCGEM1 reprograms the transcriptional network of metabolic genes and androgen-responsive genes, making it an ideal therapeutic target for prostate cancer. The present study provides significant insights into lncRNA’s role in c-Myc activation, tumor metabolism, and prostate carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“By enhancing aerobic glycolysis, the most common metabolic phenotype, known as the Warburg effect in cancer (20), overexpression of PCGEM1 facilitates anabolism to produce cellular building materials (21, 22) and consequently drives the cell to higher proliferation potential.”
BackgroundRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 2×
“These metabolic changes are critical for cancer cells to sustain rapid proliferation and adapt to a dynamic tumor microenvironment (12, 18, 19).”
BackgroundThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts
Geisler, S., & Coller, J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3679 · Cited by 1,463
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 1,100
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Long non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Calin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Xiang, J.-F., Yin, Q.-F., Chen, T., Zhang, Y., Zhang, X.-O., Wu, Z., Zhang, S., Wang, H.-B., Ge, J., Lu, X., et al. (2014) · Cell Research · doi:10.1038/cr.2014.35 · Cited by 726
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Yang, L., Lin, C., Jin, C., Yang, J. C., Tanasa, B., Li, W., Merkurjev, D., Ohgi, K. A., Meng, D., Zhang, J., et al. (2013) · Nature · doi:10.1038/nature12451 · Cited by 657
Long Intergenic Noncoding RNAs: New Links in Cancer Progression
Tsai, M.-C., Spitale, R. C., & Chang, H. Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2483 · Cited by 641
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Massie, C. E., Lynch, A., Ramos‐Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.158 · Cited by 624 · cited 3×
“In prostate-cancer cells, AR has been shown to regulate metabolic genes involved in glycolysis, PPP, fatty acid, and nucleotide synthesis (11).”
BackgroundInfluentialMYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg Effect
Yang, F., Zhang, H., Mei, Y., & Wu, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.11.004 · Cited by 510
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation
Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S., & Amati, B. (2001) · Genes & Development · doi:10.1101/gad.906601 · Cited by 499
Myc-binding-site recognition in the human genome is determined by chromatin context
Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall' Olio, V., Zardo, G., Nervi, C., Bernard, L., & Amati, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1434 · Cited by 366
The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
Newsholme, E. A., Crabtree, B., & Ardawi, M. S. M. (1985) · Bioscience Reports · doi:10.1007/bf01116556 · Cited by 364
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer
Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J. R., Connell, T., Sesterhenn, I. A., Yoshino, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12216 · Cited by 333
Self-citationPetrovics, G., Zhang, W., Makarem, M., Street, J. P., Connelly, R., Sun, L., Sesterhenn, I. A., Srikantan, V., Moul, J. W., & Srivastava, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207069 · Cited by 263
Self-citationYang, F., Xue, X., Zheng, L., Bi, J., Zhou, Y., Zhi, K., Gu, Y., & Fang, G. (2014) · The FEBS Journal · doi:10.1111/febs.12625 · Cited by 231
Myc confers androgen-independent prostate cancer cell growth
Bernard, D., Pourtier, A., Gil, J., & Beach, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19035 · Cited by 224
Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer-Associated Noncoding Gene, PCGEM1
Fu, X., Ravindranath, L., Tran, N., Petrovics, G., & Srivastava, S. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.135 · Cited by 209
Self-citationc-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., & Hockenbery, D. M. (2009) · Oncogene · doi:10.1038/onc.2009.112 · Cited by 164
Analysis of Myc-Induced Histone Modifications on Target Chromatin
Martinato, F., Cesaroni, M., Amati, B. B., & Guccione, E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003650 · Cited by 151
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Gao, L., Schwartzman, J. A., Gibbs, A., Lisac, R., Kleinschmidt, R., Wilmot, B., Bottomly, D., Coleman, I. M., Nelson, P. S., McWeeney, S. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063563 · Cited by 133
Romanuik, T. L., Wang, G., Morozova, O., Delaney, A. D., Marra, M. A., & Sadar, M. D. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-43 · Cited by 101
The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
Prensner, J. R., Sahu, A., Iyer, M. K., Malik, R., Chandler, B. C., Asangani, I. A., Poliakov, A., Vergara, I. A., Alshalalfa, M., Jenkins, R. B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1846 · Cited by 100
Max and c-Myc/Max DNA-binding activities in cell extracts.
Littlewood, T. D., Amati, B. B., Land, H., & Evan, G. I. (1992) · PubMed · Cited by 96
Amplitude modulation of androgen signaling by c-MYCPreprint
Ni, M., Chen, Y., Fei, T., Li, D., Lim, E., Liu, X. S., & Brown, M. A. (2013) · Genes & Development · doi:10.1101/gad.209569.112 · Cited by 90
ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer
Kim, R. H., Bold, R. J., & Kung, H.-J. (2009) · Autophagy · doi:10.4161/auto.5.4.8252 · Cited by 58
Self-citationDNA binding activities of c-Myc purified from eukaryotic cells.
Papoulas, O., Williams, N. G., & Kingston, R. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50042-4 · Cited by 49
Cited by
Long Noncoding RNAs in Cancer Pathways
Schmitt, A. M., & Chang, H. Y. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.010 · Cited by 2,992
Long Noncoding RNA and Cancer: A New Paradigm
Bhan, A., Soleimani, M., & Mandal, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2634 · Cited by 2,861
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,702
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Metadata
- Authors
- Hung, C.-L., Wang, L.-Y., Yu, Y.-L., Chen, H.-W., Srivastava, S., Petrovics, G., & Kung, H.-J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-12-15
- Volume
- 111
- Issue
- 52
- Pages
- 18697-18702
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079162697
- Cited by
- 302
- References
- 35
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.